gene therapy | Market Exclusive

Home Tags Gene therapy

Market Morning: Gene Therapy Deregulation, Amazon to the Movies, SEC On...

ME Staff - August 16, 2018 0

AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo...

- November 3, 2016 1

This Protocol Change Means Regenxbio Inc (NASDAQ:RGNX) Can Finally Get Started...

- July 6, 2016 0

A Close Look at What’s Driving the Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)...

Jennifer Aldershot - April 22, 2016 0

Have Markets Misinterpreted bluebird bio Inc’s (NASDAQ:BLUE) Latest Interim Update?

Roger Hannington - April 21, 2016 0

Phase Ib Topline Could be Make or Break for Voyager Therapeutics

ME Staff - February 5, 2016 0

Avalanche Puts Rebranding Operation in Motion with Latest Buyout

- February 3, 2016 0

BioMarin, Sarepta’s Loss Could Be PTC’s Gain

Roger Hannington - January 18, 2016 0

Vertex Eyes a Half Billion Dollar Boost with Upcoming sNDA Decision

Jennifer Aldershot - January 15, 2016 0

Post-Holiday Action: Movers and Shakers in Biotech

Jennifer Aldershot - December 28, 2015 0

12 Page 1 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: gene therapy